Didn't expect that! Mexico first had a worrying growth hiccup in the second quarter of 2018. Now its slowdown is looking real. Italy fell into an official recessionContinue...Read More
Last week the price of gold rose 8 bucks, and silver 16 cents.No amount of gold reserves can push a gold standard into the world as it exists today.The Monetary Metals Silver Fundamental Price was down a penny, to $15.33.The Money of the Free Market, not of Governments Monday was Memorial Day holiday in America. Last week the price of gold rose 8 bucks, and silver 16 cents. With Keith traveling in...Read More
By: Ira EpsteinGold on the August contract now in focus - higher highs, higher lows. Support around $1270 area, if break $1277.50. If a bear trap occurs, next few days gold would need to break $1306-1309:Read More
China's next tariff weapon could be rare earth mineralsThe Dow lost over 200 points today, amid concerns about an escalating U.S.-China standoff. China is reportedly considering using rare earth minerals as its next weapon in the trade dispute, and worries over bond yields also weighed on stocks, especially in the financial sector. Retail stocks were dinged too, with Abercrombie & Fitch (ANF) amon...Read More
Six years after being carved out of a handful of unwanted gold operations, Sibanye Gold Ltd. has become the world's biggest platinum miner.Building on operations spun out of Gold Fields Ltd., Sibanye became the No. 1 miner in South Africa's waning gold industry. Now, with the acquisition of Lonmin Plc, Chief Executive Officer Neal Froneman has completed Sibanye's transformation to a giant of the n...Read More
Barkerville Gold Mines of Toronto says there are 4.3 million oz. of gold in all categories, according to the latest resource estimate at its Cariboo project near Wells, Ontario. The estimate includes underground resources for the Cow, Island and Barkerville Mountain deposits.Measured and indicated resources contain 2.4 million oz. of gold in 13.2 million tonnes grading 5.60 g/t gold. That represen...Read More
Cara Therapeutics stock is higher on its phase 3 resultsU.S. and China trade relations continue to weigh heavy on stocks today, guiding all three major indexes lower. A handful of names also making moves this afternoon are power conversion specialist Eltek Ltd. (NASDAQ:ELTK), biotech Cara Therapeutics Inc (NASDAQ:CARA), and California-based CalAmp Corp. (NASDAQ:CAMP). Below, we will dive into what...Read More
What happened: Value of M&A activity skyrocketed in B.C. during the first quarter of 2019Why it matters: The jump was driven primarily by the $17.4-billion acquisition of Goldcorp Inc.A first-quarter surge in B.C.-based mergers and acquisitions (M&A) activity can be attributed to one particular mega-deal that kicked off the year, according to new data from Crosbie & Company Inc.A May 29 report rev...Read More
One fund is pacing toward its worst month in yearsThe stock market is taking a big hit this week, after several Chinese media outlets suggested Beijing could restrict the export of rare earth minerals, which are used in a variety of products, including smartphones and hybrids. Options traders are reacting to the latest salvo in the U.S.-China trade war by blasting the SPDR S&P Metals and Mining ET...Read More
Gold is still without support from its main allies, silver and oil.Mining stocks also remain in a malaise, which isn't helping the metal.A dollar index reversal would divert safe-haven demand into gold.Gold investors are biting their nails right now over gold's inability to rally in the face of widespread fears. Normally the yellow metal would be in full-blown bullish mode with as much uncerta...Read More
Gold and silver futures settled higher Wednesday for the first time in three sessions, inversely tracking a fall in stocks and other assets that tend to gain in times of growing appetite for risk. Gold for June delivery on Comex GCM19, +0.40% rose $3.90, or 0.3%, to settle at $1,281 an ounce. August gold GCQ19, +0.40% which now trades on higher volume, rose $3.80, or 0.3%, to finish at $1,286.30....Read More
Both equities sport attractively priced options at the momentThis morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes expectations for Clovis' cancer drug Rubraca are inflated. And with the latter, the analyst in coverage expressed concern over Esperion'...Read More
The equity tends to heat up in the summer monthsLike most of the stock market, the shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have struggled in May, down nearly 10% so far. However, now could be an opportune time to roll the dice on a big rebound for ALXN, for two reasons: first, pullbacks to a key trendline have preceded healthy gainsin the past; and second, the security has seasonalit...Read More
The door is wide open for downgrades on the stock A close look at the technical setup for Archer Daniels Midland Co (NYSE:ADM) reveals a number of red flags. For starters, the stock is coming off a weak earnings performance just a few weeks ago, falling below the $40 level, which represents two times a major peak from 1997, as well as its 2018 closing low. Moreover, the shares have given up suppor...Read More
There's little appetite for buying on the Street todayStocks are broadly lower today, as concerns about the economy and U.S.-China trade relations weigh. Bond yields are falling again, with the 10-year Treasury yield slipping to a nearly two-year low. The retail sector is one of the worst performing areas so far, as is the trade-sensitive tech sector. The Dow Jones Industrial Average (DJI) has dro...Read More
The shares have averaged an impressive return over the July-through-August periodApple Inc. (NASDAQ:AAPL) peaked at $215.31 on May 1, marking its highest point since Nov. 7. The shares of the iPhone maker have since shed nearly 18% -- set to snap their four-month winning streak -- amid increasing U.S.-China trade tensions. However, if history is any guide, the FAANG stock could be ready to bounce...Read More
The sporting goods retailer beat earnings expectations once againSports retailer Dick's Sporting Goods Inc (NYSE:DKS) has erased early gains, now down 4.1% at $34.30 in this morning's trading, despite the company reporting an impressive first-quarter earnings beat and upwardly revised full-year guidance. The reason behind the pullback remains unknown, as today marks the seventh quarter in a row D...Read More
Gold prices are undermined by the lack of safe-haven demand despite increased US-China trade tensions.Gold's spec positioning deteriorated markedly over May 14-21; ETF investors were on the sidelines last week.GLDM is poised to rebound next month, once downside tail risks begin to be priced into risk assets.Introduction Welcome to Orchid's Gold Weekly report. We discuss gold prices through the len...Read More
The "Deep State" powers at work could threaten the very backbone of American democracy.A new book may have Washington -- and Wall Street -- squirming in the hot seat.According to the newly-released publication, the dangers to the wealth and well-beings of good, hard-working Americans are now greater than ever!Written by a Washington insider since 1970, this book details how the author believes Ame...Read More
VSI fell to a record low last ThursdayDespite trading higher in after-hours, shares of Vitamin Shoppe Inc (NYSE:VSI) are down 3.6% to trade at $3.74 this morning -- afterpivoting lower at the open -- and earlier touching a fresh annual low of $3.68. The nutritional supplement retailer becomes the latest to dabble in cannabidiol (CBD) after announcing it was expanding its CBD hemp extract offerin...Read More